Marco Macchia Selected Research

Marco Macchia Research Topics

Disease

29	Neoplasms (Cancer) 01/2024 - 05/2005
8	Inflammation (Inflammations) 01/2023 - 01/2013
8	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2022 - 01/2013
5	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 11/2010
4	Multiple Sclerosis 12/2020 - 01/2013
3	Colonic Neoplasms (Colon Cancer) 09/2022 - 11/2010
3	Pathologic Processes 01/2021 - 06/2018
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2021
2	Disease Progression 12/2020 - 08/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2019 - 10/2018
2	Skin Neoplasms (Skin Cancer) 10/2018 - 01/2016
2	Neuralgia (Stump Neuralgia) 06/2016 - 03/2014
2	Osteoporosis 01/2015 - 10/2013
2	Breast Neoplasms (Breast Cancer) 08/2011 - 11/2005
1	Chronic Disease (Chronic Diseases) 06/2023
1	Retinal Diseases 12/2022
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2022
1	Ovarian Neoplasms (Ovarian Cancer) 12/2022
1	Wounds and Injuries (Trauma) 09/2022
1	Memory Disorders (Memory Loss) 02/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Cancer Pain 11/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2021
1	Neoplasm Metastasis (Metastasis) 08/2020
1	Carcinoma (Carcinomatosis) 08/2020
1	Chronic Pain 12/2019
1	Actinic Keratosis 05/2019
1	Hypersensitivity (Allergy) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 11/2015
1	Prostatic Neoplasms (Prostate Cancer) 06/2015
1	Glioma (Gliomas) 02/2015
1	Pain (Aches) 01/2015
1	Lung Neoplasms (Lung Cancer) 12/2013
1	Parkinson Disease (Parkinson's Disease) 04/2012

Drug/Important Bio-Agent (IBA)

12	EnzymesIBA 12/2022 - 05/2005
6	LigandsIBA 12/2022 - 06/2012
5	Olive OilIBA 06/2023 - 01/2016
5	EndocannabinoidsIBA 01/2021 - 06/2018
5	Lactate Dehydrogenase 5IBA 01/2016 - 03/2011
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 05/2005
4	CB2 Cannabinoid ReceptorIBA 06/2016 - 01/2013
3	AntioxidantsIBA 01/2024 - 11/2019
3	PolyphenolsIBA 06/2023 - 11/2019
3	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 03/2011
3	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2019
3	oleaceinIBA 01/2020 - 10/2018
3	Monoacylglycerol LipasesIBA 12/2019 - 11/2016
3	oleocanthalIBA 11/2019 - 01/2016
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2015 - 11/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 11/2013
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2023 - 11/2019
2	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 02/2021
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2021 - 01/2019
2	Matrix Metalloproteinases (MMPs)IBA 11/2019 - 05/2004
2	Epidermal Growth Factor (EGF)IBA 05/2019 - 10/2018
2	CannabinoidsIBA 08/2018 - 01/2013
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2011 - 11/2010
2	Protein Isoforms (Isoforms)IBA 11/2011 - 03/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2011 - 03/2011
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023
1	RetinoidsIBA 12/2022
1	Phosphates (Orthophosphate)IBA 09/2022
1	Metalloproteases (Metalloproteinases)IBA 09/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2022
1	Gemcitabine FDA Link 01/2022
1	PhenolsIBA 10/2021
1	LipidsIBA 02/2021
1	Phosphotransferases (Kinase)IBA 08/2020
1	tyrosine receptor (receptor, tyrosine)IBA 08/2020
1	src-Family KinasesIBA 08/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019
1	Diclofenac (SR 38)FDA LinkGeneric 05/2019
1	Neuroprotective AgentsIBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	ferulic acid (sodium ferulate)IBA 01/2017
1	caffeic acidIBA 01/2017
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2017
1	Coumaric AcidsIBA 01/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2016
1	2-oxindole (oxindole)IBA 11/2015
1	Estrogen ReceptorsIBA 02/2015
1	SugarsIBA 01/2015
1	Mannose (D-Mannose)IBA 01/2015
1	Therapeutic UsesIBA 03/2014
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2013
1	OximesIBA 12/2013
1	EstersIBA 10/2013
1	methyl 1- hydroxy- 6- phenyl- 4- (trifluoromethyl)- 1H- indole- 2- carboxylateIBA 10/2013
1	Estrogens (Estrogen)FDA Link 10/2013
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2013
1	Dopamine Receptors (Dopamine Receptor)IBA 04/2012
1	Dopamine (Intropin)FDA LinkGeneric 04/2012
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 04/2012
1	Pyruvic Acid (Pyruvate)IBA 11/2011
1	2- (3,5- dihydroxyphenyl)- 6- hydroxybenzothiazoleIBA 08/2011

Therapy/Procedure

5	Therapeutics 08/2020 - 05/2005
1	Aftercare (After-Treatment) 01/2020
1	Drug Therapy (Chemotherapy) 08/2018